Skip to main content

Study

Drug-Induced Liver Injury Associated With Turmeric and Black Pepper Based Dietary Supplements Consumption

A 2025 clinical case report describes a patient developing liver injury after consuming a turmeric and black pepper supplement.

Immune Support
Study Credibility: Low4.3/10Early findingsNot enough evidence yetTalk with your clinician
PublishedDec 2025Last reviewedJan 2026
Email this

Summary

In plain language

A 2025 clinical case report describes a patient developing liver injury after consuming a turmeric and black pepper supplement. The authors stress that clinical safety data for turmeric use remain limited, particularly concerning supplement combinations that enhance bioavailability.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This case report documents liver injury associated with turmeric and black pepper supplement use. The study details clinical presentation, diagnostic findings, and outcomes, raising awareness about potential hepatotoxicity from concentrated botanical extracts.

Research Quality Score

Scored January 20, 2026 using rubric v5_2025-02-01.

Assessment

The study provides valuable insights into potential risks associated with turmeric and black pepper supplements but is limited by its design as a case report. It lacks statistical analysis and broader applicability, though it is transparent and discloses conflicts of interest.

Category Breakdown

CategoryScoreRating
Study design5.0/10
Bias control3.3/10
Statistical methods0.0/10
Reporting completeness5.0/10
Conflicts & funding10.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

The study highlights an important area for further research, particularly the need for standardized dosing and clinical safety data for dietary supplements.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.